InvestorsHub Logo
icon url

tibbcat

01/10/06 11:03 AM

#27378 RE: neo43 #27377

on NNVC...

i read that the ceo proudly says his company is the only u.s. company to have access to the H5N1 virus?????? wierd. maybe i read this wrong.

again, if it saves the world, i'm all for it.

it's run-up is impressive, but they have a float of shares about 1/3rd of cygx. so seeing the volume there its' not suprising.

tibbcat

icon url

Rocket_173

01/10/06 11:23 AM

#27385 RE: neo43 #27377

OT - Neo could not the fast rise in NNVC be a "short squeeze" triggered by the news release. I believe they have been on the Reg-SHO list for a long time. Without something to sustain the move... I would collect my profits quickly. Tibbcat or the Wawh could comment better on these types of situations.

Rocket
icon url

Jimmy Joe

01/10/06 11:33 AM

#27393 RE: neo43 #27377

Add to this the fact that NNVCs technology is still in preliminary stages. Longterm studies should be completed before any conclusions be drawn that it is deemed safe throughout the body. I find it hard to imagine a polymer of any type being totally safe even if it is inert. Too many other aspects to consider when using something which does not break down rapidly after use and even if it did one would have to consider effects from componenets of a chemical break up.

The other thing that strikes me with this technology is does it erradicate the virus entirely? If any virals are left the patient will get sick again?

So the best defense overall is an immunity response from the
the individual under attack by the virus. A vaccine in this case would be the ultimate. In our case a vaccine which makes it harder for the virus to develope resistance against and one which can follow a gene map of the virus if it does mutate. ssDNA

Jimmy Joe


icon url

bigworld

01/10/06 1:25 PM

#27403 RE: neo43 #27377

Neo: I share your sentiments. The run up on NNVC has been too far, too fast. My DD is slow with the stock because of the difficulty in obtaining financial info. The track record of the principals looks promising, and two of the CYGX Scientific Advisory Board Members of CYGX also do the same for NNVC. The deal with Vietnam is short on particulars, but that government is certainly not going to put NNVC through 1% of the hurdles that the FDA would put them through prior to allowing the initiation of human testing. If it proved to work Vietnam and China would be sure to utilize their drug. If a pandemic occurred there are many countries who would follow. The FDA would be the last holdout.